Both Dulaglutide and Biktarvy offer similar effectiveness in symptom control, with the main difference being how quickly they act. Either drug is a viable option depending on the patient’s needs.

Both Dulaglutide and Biktarvy have similar safety profiles, with mild and transient side effects. Neither presents significant long-term safety concerns.

Both Dulaglutide and Biktarvy have a low risk of addiction when used correctly under medical supervision, with minimal potential for misuse.

Both Dulaglutide and Biktarvy are easy to use, with straightforward dosing regimens that ensure good adherence.

Both Dulaglutide and Biktarvy have some contraindications based on individual health conditions, but neither has significantly more restrictions than the other.

Both drugs offer advantages depending on treatment goals. Dulaglutide is great for fast relief, while Biktarvy is better for long-term management. The choice depends on the patient’s specific needs.